請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/90414
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 蘇剛毅 | zh_TW |
dc.contributor.advisor | Kang-Yi Su | en |
dc.contributor.author | 李雨麗 | zh_TW |
dc.contributor.author | Yu Li Li | en |
dc.date.accessioned | 2023-10-02T16:06:02Z | - |
dc.date.available | 2023-11-10 | - |
dc.date.copyright | 2023-10-02 | - |
dc.date.issued | 2023 | - |
dc.date.submitted | 2023-08-10 | - |
dc.identifier.citation | 1. Bartel, D.P., MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 2004. 116 (2): p. 281-297.
2. Griffiths-Jones, S., et al., miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research, 2006. 34: p. D140-D144. 3. Filipowicz, W., S.N. Bhattacharyya, and N. Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics, 2008. 9 (2): p. 102-114. 4. Lee, Y., et al., MicroRNA genes are transcribed by RNA polymerase II. Embo Journal, 2004. 23 (20): p. 4051-4060. 5. Lee, Y., et al., The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003. 425 (6956): p. 415-419. 6. Denli, A.M., et al., Processing of primary microRNAs by the Microprocessor complex. Nature, 2004. 432 (7014): p. 231-235. 7. Gregory, R.I., et al., The Microprocessor complex mediates the genesis of microRNAs. Nature, 2004. 432 (7014): p. 235-240. 8. Yi, R., et al., Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes & Development, 2003. 17 (24): p. 3011-3016. 9. Bernstein, E., et al., Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature, 2001. 409 (6818): p. 363-366. 10. Hammond, S.M., et al., An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature, 2000. 404 (6775): p. 293-296. 11. Hutvagner, G. and M.J. Simard, Argonaute proteins: key players in RNA silencing. Nature Reviews Molecular Cell Biology, 2008. 9 (1): p. 22-32. 12. Maniataki, E. and Z. Mourelatos, A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes & Development, 2005. 19 (24): p. 2979-2990. 13. Djuranovic, S., A. Nahvi, and R. Green, A Parsimonious Model for Gene Regulation by miRNAs. Science, 2011. 331 (6017): p. 550-553. 14. Matranga, C., et al., Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell, 2005. 123 (4): p. 607-620. 15. Lu, J. and A.G. Clark, Impact of microRNA regulation on variation in human gene expression. Genome Research, 2012. 22 (7): p. 1243-1254. 16. Sayed, D. and M. Abdellatif, Micrornas in Development and Disease. Physiological Reviews, 2011. 91 (3): p. 827-887. 17. Ivey, K.N. and D. Srivastava, MicroRNAs as Regulators of Differentiation and Cell Fate Decisions. Cell Stem Cell, 2010. 7 (1): p. 36-41. 18. Lenkala, D., et al., The impact of microRNA expression on cellular proliferation. Human Genetics, 2014. 133 (7): p. 931-938. 19. Su, Z.Y., et al., MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget, 2015. 6 (11): p. 8474-8490. 20. Inui, M., G. Martello, and S. Piccolo, MicroRNA control of signal transduction. Nature Reviews Molecular Cell Biology, 2010. 11 (4): p. 252-263. 21. Bueno, M.J. and M. Malumbres, MicroRNAs and the cell cycle. Biochimica Et Biophysica Acta-Molecular Basis of Disease, 2011. 1812 (5): p. 592-601. 22. Mahmoudi, E. and M.J. Cairns, MiR-137: an important player in neural development and neoplastic transformation. Molecular Psychiatry, 2017. 22 (1): p. 44-55. 23. Gambari, R., et al., Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Nuew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol, 2016. 49 (1): p. 5-32. 24. Landgraf, P., et al., A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 2007. 129 (7): p. 1401-14. 25. Lagos-Quintana, M., et al., Identification of novel genes coding for small expressed RNAs. Science, 2001. 294 (5543): p. 853-8. 26. Willemsen, M.H., et al., Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability. J Med Genet, 2011. 48 (12): p. 810-8. 27. Thomas, K.T., et al., Inhibition of the Schizophrenia-Associated MicroRNA miR-137 Disrupts Nrg1alpha Neurodevelopmental Signal Transduction. Cell Rep, 2017. 20 (1): p. 1-12. 28. Zhao, L., et al., miR-137, a new target for post-stroke depression? Neural Regen Res, 2013. 8 (26): p. 2441-8. 29. Hwang, W.W., et al., Distinct and separable roles for EZH2 in neurogenic astroglia. Elife, 2014. 3: p. e02439. 30. Zhang, L.H., et al., TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway. Oncogene, 2015. 34 (5): p. 600-610. 31. Lv, D.G., et al., Histone acetyltransferase KAT6A upregulates PI3K/AKT signaling through TRIM24 binding. Cancer Research, 2018. 78 (13). 32. Yu, S.L., et al., MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 2008. 13 (1): p. 48-57. 33. Su, T.J., et al., Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma. American Journal of Cancer Research, 2016. 6 (6): p. 1317-1330. 34. Chang, T.H., et al., Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C. Cancer Letters, 2017. 402: p. 190-202. 35. Neault, M., F.A. Mallette, and S. Richard, miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells. Cell Reports, 2016. 14 (8): p. 1966-1978. 36. Bemis, L.T., et al., MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Research, 2008. 68 (5): p. 1362-1368. 37. Steponaitiene, R., et al., Epigenetic Silencing of miR-137 is a Frequent Event in Gastric Carcinogenesis. Molecular Carcinogenesis, 2016. 55 (4): p. 376-386. 38. Rosenheck, R., Fast food consumption and increased caloric intake: a systematic review of a trajectory towards weight gain and obesity risk. Obes Rev, 2008. 9 (6): p. 535-47. 39. Ferrario, C.R., et al., Homeostasis Meets Motivation in the Battle to Control Food Intake. J Neurosci, 2016. 36 (45): p. 11469-11481. 40. Rossi, M.A. and G.D. Stuber, Overlapping Brain Circuits for Homeostatic and Hedonic Feeding. Cell Metab, 2018. 27 (1): p. 42-56. 41. Friedman, J.M. and J.L. Halaas, Leptin and the regulation of body weight in mammals. Nature, 1998. 395 (6704): p. 763-70. 42. Saper, C.B., T.C. Chou, and J.K. Elmquist, The need to feed: homeostatic and hedonic control of eating. Neuron, 2002. 36 (2): p. 199-211. 43. Bouret, S.G., S.J. Draper, and R.B. Simerly, Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice. J Neurosci, 2004. 24 (11): p. 2797-805. 44. Hahn, T.M., et al., Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nature Neuroscience, 1998. 1 (4): p. 271-272. 45. Broberger, C., et al., Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology, 1997. 66 (6): p. 393-408. 46. Elias, C.F., et al., Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron, 1998. 21 (6): p. 1375-1385. 47. Arora, S. and Anubhuti, Role of neuropeptides in appetite regulation and obesity - A review. Neuropeptides, 2006. 40 (6): p. 375-401. 48. Berthoud, H.R., H. Munzberg, and C.D. Morrison, Blaming the Brain for Obesity: Integration of Hedonic and Homeostatic Mechanisms. Gastroenterology, 2017. 152 (7): p. 1728-1738. 49. Meye, F.J. and R.A.H. Adan, Feelings about food: the ventral tegmental area in food reward and emotional eating. Trends in Pharmacological Sciences, 2014. 35 (1): p. 31-40. 50. Lutter, M. and E.J. Nestler, Homeostatic and Hedonic Signals Interact in the Regulation of Food Intake. Journal of Nutrition, 2009. 139 (3): p. 629-632. 51. Fang, P.H., et al., Central nervous system regulation of food intake and energy expenditure: role of galanin-mediated feeding behavior. Neurosci Bull, 2011. 27 (6): p. 407-12. 52. Sweeney, P. and Y.L. Yang, Neural Circuit Mechanisms Underlying Emotional Regulation of Homeostatic Feeding. Trends in Endocrinology and Metabolism, 2017. 28 (6): p. 437-448. 53. Sternson, S.M. and A.K. Eiselt, Three Pillars for the Neural Control of Appetite. Annual Review of Physiology, Vol 79, 2017. 79: p. 401-423. 54. Hill, J.W., Gene Expression and the Control of Food Intake by Hypothalamic POMC/CART Neurons. Open Neuroendocrinol J, 2010. 3: p. 21-27. 55. Jennings, J.H., et al., The inhibitory circuit architecture of the lateral hypothalamus orchestrates feeding. Science, 2013. 341 (6153): p. 1517-21. 56. De Lecea, L., et al., The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences of the United States of America, 1998. 95 (1): p. 322-327. 57. Sakurai, T., et al., Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior (vol 92, pg 573, 1998). Cell, 1998. 92 (5): p. U29-U29. 58. Jais, A., et al., PNOCARC Neurons Promote Hyperphagia and Obesity upon High-Fat-Diet Feeding. Neuron, 2020. 106 (6): p. 1009-+. 59. Zhou, X.H., et al., Critical Role of the Interleukin-17/Interleukin-17 Receptor Axis in Regulating Host Susceptibility to Respiratory Infection with Chlamydia Species. Infection and Immunity, 2009. 77 (11): p. 5059-5070. 60. Zhang, X.Y., et al., A MyD88-Dependent Early IL-17 Production Protects Mice against Airway Infection with the Obligate Intracellular Pathogen Chlamydia muridarum. Journal of Immunology, 2009. 183 (2): p. 1291-1300. 61. Kudva, A., et al., Influenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in Mice. Journal of Immunology, 2011. 186 (3): p. 1666-1674. 62. Conti, H.R., et al., Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. Journal of Experimental Medicine, 2009. 206 (2): p. 299-311. 63. Miyazaki, Y., et al., IL-17 Is Necessary for Host Protection against Acute-Phase Trypanosoma cruzi Infection. Journal of Immunology, 2010. 185 (2): p. 1150-1157. 64. Li, B.B., et al., The role of Th17 cells in psoriasis. Immunologic Research, 2020. 68 (5): p. 296-309. 65. Yang, P., et al., Th17 cell pathogenicity and plasticity in rheumatoid arthritis. Journal of Leukocyte Biology, 2019. 106 (6): p. 1233-1240. 66. Yan, J.B., et al., The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease. Journal of Immunology Research, 2020. 2020. 67. Li, B.Y., et al., Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjogren's syndrome by modulating the balance of Treg and Th17 cells. Stem Cell Research & Therapy, 2021. 12 (1). 68. Engelhardt, B. and R.M. Ransohoff, Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends in Immunology, 2012. 33 (12): p. 579-589. 69. Rothhammer, V., et al., Th17 lymphocytes traffic to the central nervous system independently of alpha4 integrin expression during EAE. J Exp Med, 2011. 208 (12): p. 2465-76. 70. Glatigny, S., et al., Cutting edge: loss of alpha4 integrin expression differentially affects the homing of Th1 and Th17 cells. J Immunol, 2011. 187 (12): p. 6176-9. 71. Kebir, H., et al., Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med, 2007. 13 (10): p. 1173-5. 72. Zhang, J., et al., Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of A beta (1-42)-Induced Alzheimer's Disease Model Rats. Plos One, 2013. 8 (10). 73. Fantuzzi, G., Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol, 2005. 115 (5): p. 911-9; quiz 920. 74. Winer, S., et al., Obesity predisposes to Th17 bias. European Journal of Immunology, 2009. 39 (9): p. 2629-2635. 75. Ip, B., et al., Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNFalpha production. Obesity (Silver Spring), 2016. 24 (1): p. 102-12. 76. Ahmed, M. and S.L. Gaffen, IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev, 2010. 21 (6): p. 449-53. 77. Giles, D.A., M.E. Moreno-Fernandez, and S. Divanovic, IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression. Curr Drug Targets, 2015. 16 (12): p. 1315-23. 78. Naugler, W.E. and M. Karin, The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med, 2008. 14 (3): p. 109-19. 79. Endo, Y., K. Yokote, and T. Nakayama, The obesity-related pathology and Th17 cells. Cell Mol Life Sci, 2017. 74 (7): p. 1231-1245. 80. Myers, M.G., Jr., Outstanding Scientific Achievement Award Lecture 2010: deconstructing leptin: from signals to circuits. Diabetes, 2010. 59 (11): p. 2708-14. 81. Majdic, G., Integrative role of brain and hypothalamus in the control of energy balance. Acta Chim Slov, 2009. 56 (2): p. 289-296. 82. Thaler, J.P., et al., Obesity is associated with hypothalamic injury in rodents and humans. Journal of Clinical Investigation, 2012. 122 (1): p. 153-162. 83. Ahima, R.S. and D.A. Antwi, Brain regulation of appetite and satiety. Endocrinol Metab Clin North Am, 2008. 37 (4): p. 811-23. 84. Holm, A., et al., The evolutionarily conserved miRNA-137 targets the neuropeptide hypocretin/orexin and modulates the wake to sleep ratio. Proc Natl Acad Sci U S A, 2022. 119 (17): p. e2112225119. 85. Nogueira, G., et al., Interleukin-17 acts in the hypothalamus reducing food intake. Brain Behavior and Immunity, 2020. 87: p. 272-285. 86. Takayanagi, Y., et al., Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci U S A, 2005. 102 (44): p. 16096-101. 87. Kurrasch, D.M., et al., The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning. J Neurosci, 2007. 27 (50): p. 13624-34. 88. Broberger, C., et al., Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol, 1998. 402 (4): p. 460-74. 89. Pei, H., et al., AVP neurons in the paraventricular nucleus of the hypothalamus regulate feeding. Mol Metab, 2014. 3 (2): p. 209-15. 90. Orquera, D.P., et al., The Homeodomain Transcription Factor NKX2.1 Is Essential for the Early Specification of Melanocortin Neuron Identity and Activates Pomc Expression in the Developing Hypothalamus. Journal of Neuroscience, 2019. 39 (21): p. 4023-4035. 91. Sidibe, A., et al., Expression of the orphan GPR50 protein in rodent and human dorsomedial hypothalamus, tanycytes and median eminence. Journal of Pineal Research, 2010. 48 (3): p. 263-269. 92. Lagutin, O.V., et al., Six3 repression of Wnt signaling in the anterior neuroectoderm is essential for vertebrate forebrain development. Genes & Development, 2003. 17 (3): p. 368-379. 93. Mickelsen, L.E., et al., Neurochemical Heterogeneity Among Lateral Hypothalamic Hypocretin/Orexin and Melanin-Concentrating Hormone Neurons Identified Through Single-Cell Gene Expression Analysis. Eneuro, 2017. 4 (5). 94. Gerstner, J.R., et al., Profiles of novel diurnally regulated genes in mouse hypothalamus: Expression analysis of the cysteine and histidine-rich domain-containing, zinc-binding protein 1, the fatty acid-binding protein 7 and the GTPase, ras-like family member 11b. Neuroscience, 2006. 139 (4): p. 1435-1448. 95. Bai, Y.F., et al., Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy. Mol Brain, 2019. 12 (1): p. 92. 96. Tao, R., et al., GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia. Mol Psychiatry, 2018. 23 (6): p. 1496-1505. 97. Chia, C. and T. Otto, Hippocampal Arc (Arg3.1) expression is induced by memory recall and required for memory reconsolidation in trace fear conditioning. Neurobiology of Learning and Memory, 2013. 106: p. 48-55. 98. Ang, G., et al., Deletion of AMPA receptor GluA1 subunit gene (Gria1) causes circadian rhythm disruption and aberrant responses to environmental cues. Translational Psychiatry, 2021. 11 (1). 99. Paretkar, T. and E. Dimitrov, The Central Amygdala Corticotropin-releasing hormone (CRH) Neurons Modulation of Anxiety-like Behavior and Hippocampus-dependent Memory in Mice. Neuroscience, 2018. 390: p. 187-197. | - |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/90414 | - |
dc.description.abstract | 肥胖的根本原因是卡路里的攝入超過消耗,使能量以脂質的形式在脂肪細胞中堆積。控制食慾使身體消耗量大於攝入量,是緩解肥胖的方式之一。本次研究以食慾為出發點,探討高脂肪食物(High-fat diet; HFD)與基因改變對小鼠食慾的影響。
小分子核醣核酸(Micro RNA, miRNA)是一段長度約為22個核苷酸的RNA分子,目前已被證實可以透過和目標基因的結合影響其表達。本次研究所涉及的miR-137在腦部具有很高的表現量,在先前實驗室探討miR-137全身剔除小鼠(whole-body homozygous miR-137 knockout mice)代謝的過程中,觀察到在給予小鼠HFD後,miR-137+/-小鼠體重上升較多,其進食量也比對照組(miR-137+/+)更高,由此我們猜測miR-137與食慾有著一定的關聯性。由於miR-137-/-小鼠具有早夭的特性,實驗以miR-137+/-小鼠為主,以一般飼料(Regular diet; RD)飼養到六周大成鼠時,再依據實驗設計給予HFD餵食三天,觀察到miR-137+/-小鼠相較於對照組(miR-137+/+)體重上升更快,進食量更多,其腦中的促食慾基因神经肽Y (Neuropeptide Y; NPY)也有上升。初步證實了miR-137與食慾的關聯性。 另一方面,我們試圖探討高脂肪飲食對食慾的影響。首先我們將野生型(wild-type; WT)小鼠分為兩組,分別用RD和HFD餵養,共餵養六週。觀察發現長期食用HFD的組別體重增長較多,進食量較少,但其食慾相關基因並無明顯變化。我們推測可能是因為少量的HFD即可滿足WT小鼠的日常能量需求,所以進食量減少,由此將後續實驗時間改為三天。 接下來我們將WT小鼠分為四組,第一組給予三天RD,第二組給予三天HFD,第三組給予14天HFD,第四組先用HFD飼養三天,後改用RD再飼養三天。記錄小鼠實驗前後的進食量對比發現在換HFD的當天小鼠進食量會明顯增加,隔天則下降至初始水平或更低。實驗結束後萃取小鼠腦中下視丘、海馬迴、杏仁核的RNA進行RNA測序(RNA Sequencing; RNA-Seq)。利用生物路徑分析軟體(Ingenuity Pathway Analysis; IPA)和基因富集分析(Gene Set Enrichment Analysis; GSEA)進行分析後,發現Th17 activation pathway裡的RAR Related Orphan Receptor A(RORA)可能為miR-137的目標基因,且它可能會透過白细胞介素1β(Interleukin 1 beta; IL1B)去間接的活化食慾抑制基因前脑啡黑细胞促素皮促素(Pro-opiomelanocortin; POMC)。最後我們利用免疫熒光染色發現了在長期食用HFD的小鼠腦部下視丘中有Th17 cell增多的現象。 以上結果顯示,在活體中miR-137的減少影響了小鼠對高脂肪食物的食慾;而高脂肪飲食可能會透過免疫相關的路徑去調控位於下視丘的食慾相關神經元。 | zh_TW |
dc.description.abstract | Obesity is caused by excess calories gained over calories expended, allowing energy to accumulate in fat cells as lipids. One method of reducing obesity is to control appetite so that the body consumes more than it gains. This study aimed to investigate the effects of a high-fat diet and genetic changes on appetite in mice.
MicroRNA (miRNA) is a 22-nucleotide-long RNA molecule that has been shown to influence gene expression by binding to target genes.miR-137 in this study has a high level of expression in the brain. Previously, after being fed by HFD, mice with heterozygous (miR-137+/-) gained more body weight and ate more food than the control group (miR-137+/+), indicating that miR-137 is related to appetite. Due to the early death of knockout mice, miR-137+/- mice were primarily utilized in the experiment. According to the experimental design, adult mice were fed regular diet until they were six weeks old before being given HFD for three days. Heterozygous mice gained more weight and ate more food than the control group (miR-137+/+). They also had higher appetite-stimulating gene neuropeptide Y (NPY) levels. The association between miR-137 and appetite has been tentatively confirmed. On the other hand, we attempted to investigate the impact of high-fat diet on appetite. First, wild-type mice were divided into two groups and fed RD and HFD for six weeks. The group which ate HFD gained more weight and consumed less food, but there was no significant change in appetite-related genes. We hypothesized that a small amount of HFD could meet the daily energy demand of WT mice, so food intake was reduced, and thus the follow-up experiment time was reduced to three days. WT mice were then divided into four groups as follows: the first group was fed RD for three days, the second group was fed HFD for three days, the third group was fed HFD for 14 days, and the fourth group was fed HFD for three days followed by RD for three days. The mice's food consumption was recorded before and after the experiment. It was discovered that the food intake of mice increased significantly on the day of the HFD change and then decreased to the initial level or lowered the following day. Following the experiment, RNA was extracted from the hypothalamus, hippocampus, and amygdala for RNA sequencing. Using Ingenuity Pathway Analysis and Gene Set Enrichment Analysis, it was discovered that RAR Related Orphan Receptor A (RORA) in the Th17 activation pathway might be the target gene of miR-137. It may also indirectly activate the appetite suppressor gene Pro-opiomelanocortin (POMC) via Interleukin 1 beta (IL1B). Finally, we found an increase in Th17 cells in the brain's hypothalamus of mice consuming long-term HFD using immunofluorescence staining. These findings demonstrated that decreasing miR-137 in vivo affected mice's appetite for high-fat foods. On the other hand, high-fat diet may regulate appetite-related neurons in the hypothalamus via an immune-related pathway, which needs to be confirmed in future research. | en |
dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-10-02T16:06:01Z No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2023-10-02T16:06:02Z (GMT). No. of bitstreams: 0 | en |
dc.description.tableofcontents | 國立臺灣大學碩士學位論文口試委員審定書 I
致謝 II 中文摘要 V ABSTRACT VII 1. INTRODUCTION 1 1.1 MicroRNA 1 1.1.1 MicroRNA 1 1.1.2 miR-137 2 1.2 Appetite 3 1.2.1 Homeostatic Feeding 4 1.2.2 Hedonic Feeding 4 1.2.3 Appetite-related genes 5 1.3 T helper 17 cells 6 1.3.1 T helper 17 cells 6 1.3.2 Th17 cells with obesity 7 1.4 Study Background 7 1.5 Specific aim 8 2. MATERIALS AND METHODS 9 2.1 miR-137 knockout mice model 9 2.1.1 Animals keeping 9 2.1.2 Tail DNA extraction and genotyping 9 2.2 High-fat-diet feeding 11 2.2.1 Long-term high-fat diet feeding 11 2.2.2 Short-term high-fat diet feeding 11 2.2.3 Group feeding 11 2.3 Real-time quantitative RT-PCR 12 2.3.1 For target genes in the SYBR Green system 12 2.3.2 For miR-137 in the TaqMan probe system 12 2.4 Immunofluorescence 13 2.5 Determination of miR-137 target mRNA 14 2.6 RNA Sequencing Analysis 14 2.7 Statistical Analysis 15 3. RESULTS 16 3.1 Long-term high-fat diet did not alter wild-type mice's appetite gene expression level. 16 3.2 Wild-type mice's food intake increased during the transition day. 16 3.3 The third group's gene expression in the hypothalamus differed greatly. 17 3.4 Gene set enrichment analysis (GSEA) of RNA-seq data in the hypothalamus of the brain 18 3.5 Pathways analysis by Ingenuity pathway analysis (IPA) 18 3.6 Association network of appetite genes and Th17 activation pathway 18 3.7 The appetite-suppressing gene POMC was significantly increased in the hypothalamus of mice fed high-fat diet for 14 days. 19 3.8 The Th17 cell maker IL-17A was dose-dependent in the four groups of the hypothalamus. 19 3.9 Th17 cells are increased in the hypothalamus of mice fed long-term high-fat diet. 20 3.10 IL-17A co-localizes with POMC in the hypothalamus 20 3.11 miR-137 +/- mice consumed more food on a high-fat diet for a short time. 20 3.12 The RORA gene expression increased in the brains of miR-137+/- mice. 21 4. CONCLUSIONS 22 5. DISCUSSION 23 5.1 Group feeding 23 5.2 miR-137 mouse model in this study 24 5.3 Target genes of miR-137 24 5.4 Th17 cell and appetite 25 5.5 RNA-seq analysis 26 6. FIGURES 28 7. TABLES 48 8. SUPPLEMENTARY DATA 51 9. APPENDIX 55 REFERENCE 62 | - |
dc.language.iso | en | - |
dc.title | 探討miR-137和高脂飲食對食慾的影響 | zh_TW |
dc.title | To Investigate the Effects of miR-137 and High-Fat Diet on Appetite in Mice | en |
dc.type | Thesis | - |
dc.date.schoolyear | 111-2 | - |
dc.description.degree | 碩士 | - |
dc.contributor.oralexamcommittee | 林亮音;楊雅倩;郭靜穎;潘思樺 | zh_TW |
dc.contributor.oralexamcommittee | LIANG-IN LIN;YA-CHIEN YANG;CHING-YING KUO;Szu-Hua Pan | en |
dc.subject.keyword | 小分子核糖核酸-137,高脂肪飼料,基因剔除鼠,食慾,免疫, | zh_TW |
dc.subject.keyword | miR-137,high-fat diet,knockout mice,appetite,immunity, | en |
dc.relation.page | 74 | - |
dc.identifier.doi | 10.6342/NTU202301658 | - |
dc.rights.note | 同意授權(限校園內公開) | - |
dc.date.accepted | 2023-08-10 | - |
dc.contributor.author-college | 醫學院 | - |
dc.contributor.author-dept | 醫學檢驗暨生物技術學系 | - |
dc.date.embargo-lift | 2025-08-09 | - |
顯示於系所單位: | 醫學檢驗暨生物技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-111-2.pdf 目前未授權公開取用 | 4.28 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。